Advances in PET Imaging of the CXCR4 Receptor: [68Ga]Ga-PentixaFor

Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors

(2023) Alexander Weich et al.   CLINICAL NUCLEAR MEDICINE

68Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma

(2023) Marius E. Mayerhoefer et al.   CLINICAL NUCLEAR MEDICINE

CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors

(2023) Ingo Hartlapp et al.   JOURNAL OF NUCLEAR MEDICINE

Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging

(2023) Aleksander Kosmala et al.   MOLECULAR IMAGING AND BIOLOGY

Diagnostic value of [68Ga]Ga-Pentixafor versus [18F]FDG PET/CTs in non-small cell lung cancer: a head-to-head comparative study

(2023) Seyed Ali Mirshahvalad et al.   NUCLEAR MEDICINE COMMUNICATIONS

Accuracy of Gallium-68 Pentixafor Positron Emission Tomography–Computed Tomography for Subtyping Diagnosis of Primary Aldosteronism

(2023) Jinbo Hu et al.   JAMA Network Open

The Value of Targeting CXCR4 With 68Ga-Pentixafor PET/CT for Subtyping Primary Aldosteronism

(2023) Yanqing Zheng et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Usefulness of 68Ga-Pentixafor PET/CT on Diagnosis and Management of Cushing Syndrome

(2022) Jie Ding et al.   CLINICAL NUCLEAR MEDICINE

Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [68Ga]Ga-PentixaFor PET/CT

(2022) Sebastian E. Serfling et al.   MOLECULAR IMAGING AND BIOLOGY

Imaging CXCR4 receptors expression for staging multiple myeloma by using 68Ga-Pentixafor PET/CT: comparison with 18F-FDG PET/CT

(2022) Amit Singh Shekhawat et al.   BRITISH JOURNAL OF RADIOLOGY

Association of 18F‐Fluorodeoxyglucose Positron Emission Tomography and Angiographic Progression of Disease in Large‐Vessel Vasculitis

(2022) Kaitlin A. Quinn et al.   Arthritis & Rheumatology

[68Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors’ density by immunochemistry techniques

(2022) Ankit Watts et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [68Ga]Ga-Pentixafor /[177Lu]Lu-Pentixather

(2021) Sarah M. Jacobs et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Improved primary staging of marginal zone lymphoma by addition of CXCR4-directed PET/CT

(2021) Johannes Duell et al.   JOURNAL OF NUCLEAR MEDICINE

Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach

(2021) Philipp Linde et al.   CANCER IMAGING

CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment

(2021) Sara Santagata et al.   Frontiers in Oncology

Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results

(2021) Serkan Kuyumcu et al.   ANNALS OF NUCLEAR MEDICINE

CXCR4 PET/MRI for follow-up of gastric mucosa-associated lymphoid tissue lymphoma after first-line H. pylori eradication

(2021) Marius Mayerhoefer et al.   BLOOD

68Ga-Pentixafor-PET/CT imaging represents a novel approach to detect chemokine receptor CXCR4 expression in myeloproliferative neoplasms

(2021) Sabrina Kraus et al.   JOURNAL OF NUCLEAR MEDICINE

Functional characterization of adrenocortical masses in nononcological patients using [68Ga]-pentixafor

(2021) Jie Ding et al.   JOURNAL OF NUCLEAR MEDICINE

CXCR4-Directed PET/CT with [68Ga]Pentixafor in Central Nervous System Lymphoma: A Comparison with [18F]FDG PET/CT

(2021) Zhenying Chen et al.   MOLECULAR IMAGING AND BIOLOGY

Semi-quantitative measurements of chemokine receptor 4-targeted 68Ga-pentixafor PET/CT in response assessment of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma

(2021) Qingqing Pan et al.   EJNMMI Research

Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism

(2020) Jie Ding et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

CXCR4-targeted positron emission tomography imaging of central nervous system B-cell lymphoma

(2020) Peter Herhaus et al.   JOURNAL OF NUCLEAR MEDICINE

Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG

(2020) Qingqing Pan et al.   EJNMMI Research

Clinical Molecular Imaging of Pulmonary CXCR4 Expression to Predict Outcome of Pirfenidone Treatment in IPF

(2020) Thorsten Derlin et al.   CHEST

18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features

(2020) Xiang Zhou et al.   Cancers

Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI

(2020) Angelika M. Starzer et al.   CLINICAL NUCLEAR MEDICINE

CXCR7: a β-arrestin-biased receptor that potentiates cell migration and recruits β-arrestin2 exclusively through Gβγ subunits and GRK2

(2020) Huong Thi Nguyen et al.   Cell and Bioscience

[68Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with 18F[FDG] PET Imaging

(2020) Ismaheel O. Lawal et al.   Biomolecules

[68Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery

(2019) Xiang Li et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

68Ga-pentixafor PET/CT for imaging of chemokine receptor-4 expression in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma: comparison to 18F-FDG PET/CT

(2019) Yaping Luo et al.   JOURNAL OF NUCLEAR MEDICINE

[68Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas

(2019) Maria Breun et al.   Frontiers in Oncology

The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases

(2019) Eva M. García-Cuesta et al.   Frontiers in Endocrinology

CXCR4-Directed Imaging in Solid Tumors

(2019) Rudolf A. Werner et al.   Frontiers in Oncology

Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT

(2019) Qingqing Pan et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Imaging Inflammation in Atherosclerosis with CXCR4-directed 68Ga-Pentixafor PET/CT - Correlation with 18F-FDG PET/CT

(2019) Malte Kircher et al.   JOURNAL OF NUCLEAR MEDICINE

Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics

(2018) Stefan Habringer et al.   Theranostics

CXCR4-directed theranostics in oncology and inflammation

(2018) Malte Kircher et al.   ANNALS OF NUCLEAR MEDICINE

PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma

(2018) Tibor Vag et al.   EJNMMI Research

[68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques

(2017) Xiang Li et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing AdenomaNovelty and Significance

(2017) Britta Heinze et al.   HYPERTENSION

68Ga-Pentixafor PET/CT Imaging of Chemokine Receptor CXCR4 in Chronic Infection of the Bone: First Insights

(2017) Caroline Bouter et al.   JOURNAL OF NUCLEAR MEDICINE

Integrating MRI and Chemokine Receptor CXCR4-Targeted PET for Detection of Leukocyte Infiltration in Complicated Urinary Tract Infections After Kidney Transplantation

(2017) Thorsten Derlin et al.   JOURNAL OF NUCLEAR MEDICINE

Clinical Molecular Imaging of Chemokine Receptor CXCR4 Expression in Atherosclerotic Plaque Using68Ga-Pentixafor PET: Correlation with Cardiovascular Risk Factors and Calcified Plaque Burden

(2017) Desiree Weiberg et al.   JOURNAL OF NUCLEAR MEDICINE

[177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent

(2017) Margret Schottelius et al.   Theranostics

[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values

(2017) Constantin Lapa et al.   Theranostics

Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach

(2017) Rudolf A. Werner et al.   Theranostics

First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers

(2016) T. Vag et al.   JOURNAL OF NUCLEAR MEDICINE

Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68 Ga-Pentixafor for PET

(2016) Fabien Hyafil et al.   JOURNAL OF NUCLEAR MEDICINE

[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience

(2016) Constantin Lapa et al.   Oncotarget

68Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma

(2016) Constantin Lapa et al.   Theranostics

In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma

(2015) K. Philipp-Abbrederis et al.   EMBO Molecular Medicine

First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease

(2015) K. Herrmann et al.   JOURNAL OF NUCLEAR MEDICINE

Biodistribution and Radiation Dosimetry for the Chemokine Receptor CXCR4-Targeting Probe 68Ga-Pentixafor

(2015) K. Herrmann et al.   JOURNAL OF NUCLEAR MEDICINE

Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging

(2015) Hans Jürgen Wester et al.   Theranostics

Design, Synthesis, and Functionalization of Dimeric Peptides Targeting Chemokine Receptor CXCR4

(2011) Oliver Demmer et al.   JOURNAL OF MEDICINAL CHEMISTRY

PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent

(2011) E. Gourni et al.   JOURNAL OF NUCLEAR MEDICINE